Track oxyntomodulin in Peptimes™
Oxyntomodulin is a peptide of 37 amino acids that begins with the full sequence of glucagon. FDA's substance registry also lists human oxyntomodulin as enteroglucagon and glucagon 1-37. (Source: FDA's substance registry (GSRS).)
Is oxyntomodulin FDA-approved?
No. Oxyntomodulin isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.
Oxyntomodulin
Also: OXM, enteroglucagon, glucagon 1-37
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- SubcutaneousOther
- Updated
- 1 Nov 2026
US regulatory status
What studies have looked at
Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.
- In humans
In a randomized, double-blind, placebo-controlled crossover study in 13 healthy adults, oxyntomodulin reduced how much they ate at a buffet meal (on average about 19% less) and lowered hunger scores. It did not cause nausea.
Source: PMID 14557443, checked 1 Nov 2026
How to track it in Peptimes
Add oxyntomodulin in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: subcutaneous or Other. Choose the one that matches each dose.
- Logging: the amount you took, the route and how you feel.
- Injection sites: subcutaneous doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Doses logged as Other skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell oxyntomodulin or any other compound.
More sources
- FDA, Global Substance Registration System, Oxyntomodulin human, checked 1 Nov 2026: its sequence of 37 amino acids and the names enteroglucagon and glucagon 1-37.
- FDA, Drugs@FDA, searched 1 Nov 2026: no application lists oxyntomodulin as an active ingredient.